C

China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062

Watchlist Manager
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
Watchlist
Price: 21.81 CNY 0.37% Market Closed
Market Cap: 22.4B CNY
Have any thoughts about
China Resources Double-Crane Pharmaceutical Co Ltd?
Write Note

China Resources Double-Crane Pharmaceutical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Resources Double-Crane Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
C
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
Cash from Operating Activities
ÂĄ1.9B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
14%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Operating Activities
ÂĄ3.1B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Operating Activities
ÂĄ7.8B
CAGR 3-Years
71%
CAGR 5-Years
22%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Operating Activities
ÂĄ4.5B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Operating Activities
-ÂĄ615.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is China Resources Double-Crane Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.9B CNY

Based on the financial report for Jun 30, 2024, China Resources Double-Crane Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 1.9B CNY.

What is China Resources Double-Crane Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%

Over the last year, the Cash from Operating Activities growth was 44%. The average annual Cash from Operating Activities growth rates for China Resources Double-Crane Pharmaceutical Co Ltd have been 13% over the past three years , 6% over the past five years , and 14% over the past ten years .

Back to Top